Avipsha Datta, Department of Biophysics and Molecular Biology, University of Calcutta
Covid-19 Vaccine- the one thing we are very much hoping for right now! Well, here is some news update that might give us a little more hope. The Drugmaker Company Moderna has announced that it is preparing to launch its potential Coronavirus vaccine mRNA-1273.Meanwhile, Johnson and Johnson is planning to start testing it’s experiment Covid-19 vaccine among those aged 12 to 18.
Moderna CEO Stephanie Bancel has said in a press conference in recent times that they are actively preparing to launch its potential Coronavirus vaccine soon. They have signed a number of supply agreements with the governments around the globe.
According to the reports, the company has received $1.1 billion in customer deposits for the shots during the third quarter. Last week, Moderna has completed enrollment for the 30,000 Stage-3 Clinical trials. Till then, more than 25,650 volunteers have received the second of the company’s two-dose Covid-19 vaccine. Most of the participants were from diverse communities and 42% were at a high risk of severe diseases.
Moderna has further stated that it would seek emergency FDA authorization to use vaccine high-risk groups if an interim assessment of its trail showed that the vaccine was at least 70% effective. Moderna is hopeful that we might have an approved Covid-19 vaccine by the end of this year.
Also read: EFFECT OF MISSENSE VARIATIONs: REVELEALED
- The Corrosion Prediction from the Corrosion Product Performance
- Nitrogen Resilience in Waterlogged Soybean plants
- Cell Senescence in Type II Diabetes: Therapeutic Potential
- Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP
- AI Literacy in Early Childhood Education: Challenges and Opportunities
One thought on “Moderna: Covid-19 Vaccine- Sooner than we think?”